| Financial Year |
March 31 2023 |
| Monetary Funds |
8,177,868,635.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
637,704.06 |
| Accounts Receivable |
231,234,776.43 |
| Advances to Suppliers |
1,304,354,404.31 |
| Other Receivables |
372,520,881.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
13,539,404,634.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
168,260,994.92 |
| Total Current Assets |
23,794,282,031.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,054,401,453.82 |
| Investment Properties |
22,426,157.66 |
| Fixed Assetes |
14,677,240,180.40 |
| Under-construction Projects |
1,095,498,247.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,506,903,954.17 |
| R&D expenses |
-- |
| Goodwill |
724,094,298.74 |
| Long-Term Deferred and Prepaid Expenses |
1,456,709,662.15 |
| Deferred Income Tax Assets |
286,812,742.31 |
| Other Non-Current Assets |
472,214,899.94 |
| Sub-Total of Non-Current Assets |
25,477,441,462.77 |
| Total Assets |
49,271,723,493.96 |
| Short-Term Loans |
7,415,733,963.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
61,720,000.00 |
| Accounts Payable |
2,821,582,492.71 |
| Accounts Received In Advance |
2,033,157.49 |
| Employee Compensation Payable |
295,778,920.65 |
| Taxes Payable |
386,896,689.93 |
| Interest Payable |
-- |
| Dividend Payable |
30,582,832.12 |
| Other payables |
1,297,089,102.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,214,918,061.17 |
| Other Current Liabilities |
99,358,726.74 |
| Sub-Total of Current Liabilities |
15,762,044,633.16 |
| Long-term Loans |
3,456,390,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
102,119,769.39 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
926,159,052.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,752,778,374.87 |
| Total Liabilities |
20,514,823,008.03 |
| Paid-In Capital(Or Share Stock) |
4,847,312,564.00 |
| Capital Surplus |
9,176,119,931.92 |
| Surplus Reserve |
1,649,711,907.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,884,268,157.80 |
| Minority Stockholder's Interest |
2,288,070,285.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
26,468,830,200.20 |
| Owner's Equity（Stockholder's Equity） |
28,756,900,485.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
49,271,723,493.96 |
